What happened

Semtrio’s Insights page carries a headline about choosing an adviser for IFRS S1/S2 reporting. The material supplied from that page establishes the subject of the article, but does not provide substantive discussion of how an organisation should choose a provider.

The available extract also contains a notice concerning Semtrio marketing communications. It says that people who subscribe agree to receive those communications and may later opt out.

No publication date is shown in the evidence provided. Nor does the extract identify a particular advisory firm, set out a recommended procurement process or describe any specific reporting engagement.

Why it matters

Companies seeking external support for IFRS S1/S2 work need information that allows providers to be assessed on a comparable basis. The supplied text does not state which qualifications, services, methods, sector experience, delivery arrangements or other attributes should be considered.

It also does not explain the reporting tasks an adviser may undertake, the role an organisation should retain internally, or how advisory support connects to a broader disclosure programme. Readers should therefore not treat the available extract as a basis for selecting or ranking advisers.

The limited source text makes no claim about the applicability of IFRS S1 or IFRS S2 to particular companies, jurisdictions or reporting periods. It likewise provides no information on costs, timelines, assurance, data requirements or implementation outcomes.

What readers should do next

Teams considering advisory support should obtain the complete article or other detailed documentation before relying on Semtrio’s material for a provider comparison. They should distinguish between the page’s stated topic and any selection guidance that may appear in fuller content but is not present in the supplied evidence.

For now, the only supported conclusion is that Semtrio has published an Insights page focused on the choice of an IFRS S1/S2 reporting adviser, alongside a subscription and opt-out notice.